Mergers & Acquisitions Taxation

Contact(s)

“Their work is consistently superior, and delivered on time. They are precise, succinct and proactive.” – Chambers USA

Our tax lawyers are known for their innovative tax-free and tax-efficient M&A structures, which have been employed in the largest and most complex domestic and international public and private mergers and acquisitions, spin-offs, reverse morris trusts (RMTs), inversions, divestitures and joint ventures, both in conjunction with our corporate attorneys and as special tax counsel. We also routinely handle acquisition debt and equity offerings as well as more unique financing arrangements.

  • Salix Pharmaceuticals, Ltd. in its pending $14.5 billion acquisition by Valeant Pharmaceuticals International, Inc.
  • Forbes Media LLC on its pending sale of a majority stake to a group of international investors as part of Forbes Media’s global growth strategy.
  • Salix Pharmaceuticals in its $2.7 billion merger with a subsidiary of Cosmo Pharmaceuticals to form Salix Pharmaceuticals, plc.
  • Mercuria in its pending acquisition of JPMorgan’s physical energy and commodities business.
  • Elan Corporation plc in its $8.6 billion acquisition by Perrigo Company.
  • Elan Corporation plc in its tax-free spin-off of its drug discovery business, Prothena Corporation plc.
  • JPMorgan in connection with Dell’s $24.9 acquisition by Michael Dell and Silver Lake Partners.
  • Procter & Gamble Co. in its sale of the Pringles Group to Kellogg.
  • Procter & Gamble Co. in the proposed tax-free distribution and acquisition of its snack business to Diamond Foods Inc.
  • Quest Software, Inc. Chairman and CEO Vincent Smith in the $2.4 billion sale of Quest Software to Dell Inc.
  • Vertis Holdings in connection with its section 363 sale to Quad/Graphics.
  • Towers Watson & Co. in its $435 million acquisition of Extend Health Inc., its acquisition of Liazon Corporation and the sale of its reinsurance brokerage business to Jardine Lloyd Thompson.
  • Pfizer in the $2.38 billion sale of its Capsugel unit to Kohlberg Kravis Roberts & Co. (KKR).
  • Pfizer in its $3.6 billion acquisition of King Pharmaceuticals.
  • AngioDynamics in its acquisitions of Navilyst and Vortex Medical.
  • Pfizer in the $16.6 billion sale of its consumer healthcare division to Johnson & Johnson.
  • Pfizer in its $68 billion acquisition of Wyeth.
  • Pfizer in its $60 billion acquisition of Pharmacia.
  • Pfizer in its $114.5 billion hostile takeover of Warner-Lambert, creating one of the world’s largest drug companies.
  • CVC Capital Partners Group in its bid for Barclays' iShares unit.
  • Celanese Corporation's sale of its PVOH business to Sekisui Chemical Co. Ltd.
  • The Procter & Gamble Co. in its $57 billion acquisition of The Gillette Company.

NEWS

RESOURCES

2 Attorneys

Blakemore, Adam Partner London
T. +44 (0) 20 7170 8697
Swartz, Linda Z. Partner New York
T. +1 212 504 6062

Contact(s)

Linda Z. Swartz
+1 212 504 6062 
linda.swartz@cwt.com
v-card

March 6-7 | LendIt 2017 Conference | Javits Center | New York City

Cadwalader is a proud sponsor of the world’s biggest show in lending and fintech.

Cadwalader Subscription Center